Literature DB >> 29080220

A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis.

Paola Minetto1, Fabio Guolo1, Marino Clavio1, Annalisa Kunkl2, Nicoletta Colombo1, Enrico Carminati1, Livia Giannoni1, Filippo Ballerini1, Roberto Massimo Lemoli1, Marco Gobbi1, Maurizio Miglino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29080220     DOI： 10.1002/ajh.24956

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Luisa Lorenzi; Silvia Lonardi; Donatella Vairo; Andrea Bernardelli; Michela Tomaselli; Mattia Bugatti; Sara Licini; Mariachiara Arisi; Lorenzo Cerroni; Alessandra Tucci; William Vermi; Silvia Clara Giliani; Fabio Facchetti
Journal:  Am J Surg Pathol       Date:  2021-10-01       Impact factor: 6.298

2.  Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.

Authors:  Siba El Hussein; Mariko Yabe; Wei Wang; Naveen Pemmaraju; Sanam Loghavi; Fatima Zahra Jelloul; Hong Fang; L Jeffrey Medeiros; W Richard Burack; Andrew G Evans; Jane L Liesveld; John M Bennett
Journal:  EJHaem       Date:  2022-07-03

3.  Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.

Authors:  Wenbin Xiao; Alexander Chan; Michael R Waarts; Tanmay Mishra; Ying Liu; Sheng F Cai; Jinjuan Yao; Qi Gao; Robert L Bowman; Richard P Koche; Isabelle S Csete; Nicole L DelGaudio; Andriy Derkach; Jeeyeon Baik; Sophia Yanis; Christopher A Famulare; Minal Patel; Maria E Arcila; Maximilian Stahl; Raajit K Rampal; Martin S Tallman; Yanming Zhang; Ahmet Dogan; Aaron D Goldberg; Mikhail Roshal; Ross L Levine
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.